Circulating CXCR6 + PD-1 + CD8 T cells are associated with liver inflammation and disease severity in hepatitis flares
Clinical and Molecular Hepatology · 17.11.2026
DOI: 10.3350/cmh.2026.0318 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Molecular Hepatology, online erschienen am 17.11.2026. Verfasst von Roni Souleiman und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany.
Abstract (Originalsprache)
Background/Aims: Marked hepatitis flares, defined in this study as alanine aminotransferase (ALT) elevations exceeding five times the upper limit of normal, occur in acute and chronic liver diseases and may be associated with severe liver injury. However, the circulating immune profiles associated with the extent of liver injury remain incompletely characterized. We aimed to characterize circulating CD8 T cell phenotypes and soluble immune mediators during hepatitis flares across different etiologies.
Methods
In a retrospective cross-sectional analysis, soluble immune mediators and circulating CD8 T cell phenotypes were analyzed in 71 patients with hepatitis flares using Luminex assays and spectral flow cytometry. Exploratory functional experiments included in vitro PBMC stimulation and co-culture of sorted CD8 T cell subsets with Huh7 hepatoma cells. A public HBV single-cell RNA-sequencing dataset was reanalyzed to contextualize circulating and intrahepatic CD8 T cell states.
Results
Circulating CXCR6+PD-1+ CD8 T cell frequencies were associated with biochemical markers of liver injury and dysfunction. HLA-DR expression within this subset was associated with the hepatocyte injury index, bilirubin levels, and plasma CXCL10 (IP-10) concentrations. Activation-marker and granzyme expression differed across flare etiologies, and CXCR6+PD-1+ CD8 T cells retained inducible effector responses following cytokine stimulation. Reanalysis of a public HBV scRNA-seq dataset identified a liver-enriched CXCR6/PDCD1/HLA-DRAhi GZMKhi CD8 T cell state.
Conclusion
Circulating CXCR6+PD-1+ CD8 T cells represent an activation-associated population that correlates with biochemical liver injury during hepatitis flares and retains inducible effector capacity. Whether these cells contribute to or reflect ongoing liver inflammation remains to be determined.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany.
- TWINCORE Center of Experimental and Clinical Infection Research, Hannover, Germany.
- German Center for Infection Research (DZIF), Hannover, Germany.
- Center for Individualized Infection Medicine (CiiM), Hannover, Germany.
- Cluster of Excellence Resolving Infection Susceptibility (RESIST; EXC 2155), Hannover Medical School, Hannover, Germany.
- Institute of Immunology, Hannover Medical School, Hannover, Germany.
Zitieren
APA
Souleiman, R., Chou, Y. H., Yang, T., Freyer, E., Carpentier, A., Dey, S., Niehaus, C., Wintersteller, H., Falk, C., Maasoumy, B., Ravens, S., Wedemeyer, H., Kraft, A., Heinrich, B., & Cornberg, M. (2026). Circulating CXCR6 + PD-1 + CD8 T cells are associated with liver inflammation and disease severity in hepatitis flares. Clinical and Molecular Hepatology. https://doi.org/10.3350/cmh.2026.0318
Vancouver
Souleiman R, Chou YH, Yang T, Freyer E, Carpentier A, Dey S, et al. Circulating CXCR6 + PD-1 + CD8 T cells are associated with liver inflammation and disease severity in hepatitis flares. Clinical and Molecular Hepatology. 2026. doi:10.3350/cmh.2026.0318
BibTeX
@article{Souleiman2026,
author = {Souleiman, Roni and Chou, Yin-Han and Yang, Tao and Freyer, Erich and Carpentier, Arnaud and Dey, Suparna and Niehaus, Christian and Wintersteller, Hannah and Falk, Christine and Maasoumy, Benjamin and Ravens, Sarina and Wedemeyer, Heiner and Kraft, Anke and Heinrich, Bernd and Cornberg, Markus},
title = {Circulating CXCR6 + PD-1 + CD8 T cells are associated with liver inflammation and disease severity in hepatitis flares},
journal = {Clinical and Molecular Hepatology},
year = {2026},
doi = {10.3350/cmh.2026.0318}
}
EUVIMED